Canada - TSX-V:ADK - CA2524423068 - Common Stock
The current stock price of ADK.CA is 0.305 CAD. In the past month the price increased by 10.91%. In the past year, price decreased by -14.08%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VHI.CA | VITALHUB CORP | 109.6 | 687.30M | ||
KSI.CA | KNEAT.COM INC | N/A | 558.72M | ||
NURS.CA | HYDREIGHT TECHNOLOGIES INC | N/A | 189.30M | ||
KDA.CA | KDA GROUP INC | N/A | 50.51M | ||
CHS.CA | COMPREHENSIVE HEALTHCARE SYS | N/A | 11.13M | ||
AVCR.CA | AVRICORE HEALTH INC | N/A | 7.09M | ||
KOVO.CA | KOVO+ HOLDINGS INC | N/A | 7.08M | ||
EKG.CA | CARDIOCOMM SOLUTIONS INC | N/A | 2.96M |
Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company is headquartered in Brossard, Quebec. The company went IPO on 2000-09-27. The company markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
DIAGNOS INC
7005 Taschereau Blvd Suite 340
Brossard QUEBEC J4Z 1A7 CA
CEO: Andre Larente
Employees: 16
Phone: 14506788882
The current stock price of ADK.CA is 0.305 CAD. The price increased by 1.67% in the last trading session.
The exchange symbol of DIAGNOS INC is ADK and it is listed on the TSX Venture Exchange exchange.
ADK.CA stock is listed on the TSX Venture Exchange exchange.
DIAGNOS INC (ADK.CA) has a market capitalization of 31.41M CAD. This makes ADK.CA a Nano Cap stock.
DIAGNOS INC (ADK.CA) currently has 16 employees.
DIAGNOS INC (ADK.CA) has a support level at 0.27 and a resistance level at 0.31. Check the full technical report for a detailed analysis of ADK.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ADK.CA does not pay a dividend.
DIAGNOS INC (ADK.CA) will report earnings on 2025-11-19.
DIAGNOS INC (ADK.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).
ChartMill assigns a technical rating of 7 / 10 to ADK.CA. When comparing the yearly performance of all stocks, ADK.CA turns out to be only a medium performer in the overall market: it outperformed 58% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to ADK.CA. Both the profitability and financial health of ADK.CA have multiple concerns.
Over the last trailing twelve months ADK.CA reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS decreased by -11.89% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -117.88% | ||
ROE | -1838.87% | ||
Debt/Equity | 1.23 |